beta-blocker
Think of adrenaline as the body's accelerator pedal for the heart: when you are stressed or frightened it presses down, and the heart races. A beta-blocker is like a cover placed over part of that pedal, so the signal cannot push as hard. The result is a slower, gentler heartbeat and lower blood pressure.
Chemically, beta-blockers are antagonists at beta-adrenergic receptors, a family of G-protein-coupled receptors that normally respond to adrenaline and noradrenaline. The classic chemical signature is an aryloxypropanolamine backbone, an aromatic ring linked through an oxygen to a propanolamine chain carrying a secondary amine. By occupying the receptor without activating it, the drug blunts the sympathetic 'fight-or-flight' drive on the heart.
Members differ in selectivity. So-called cardioselective agents such as metoprolol and atenolol prefer the beta-1 receptor of the heart, while older non-selective agents such as propranolol also block beta-2 receptors in the airways and blood vessels. They are used for high blood pressure, angina, certain arrhythmias, and after heart attacks.
An honest caveat: because beta-2 blockade can tighten airways, non-selective beta-blockers are used cautiously in people with asthma. Abruptly stopping a beta-blocker can also cause a rebound surge in heart rate, so doses are usually tapered.
Propranolol, the first widely used beta-blocker, is a non-selective antagonist whose aryloxypropanolamine structure became the template for the entire class.
A non-selective beta-blocker built on the class-defining aryloxypropanolamine scaffold.
The shared 'olol' suffix in generic names (propranolol, metoprolol, atenolol) is a clue to the class — though it reflects naming convention, not a guarantee of identical pharmacology.